Prostate Biopsy under Navigation of Histoscanning Technology
Abstract
The purpose: to evaluate the benefits of targeted prostate biopsy under navigation of the histoscanning technology. Material and methods. During the period from mid- September to December 2013 according to the histoscanning procedure with targeted biopsies were examined 27 patients aged from 47 to 98 years with suspected prostate cancer, aimed at the urology department of “Clinical Hospital №1” of the Presidential Administration of the Russian Federation to perform transrectal prostate multifocal biopsies. All patients underwent complex clinical examination and ultrasound examination, which included: a study in grayscale using ultrasonic angiography, sonoelastography and histoscanning. Results. The sensitivity of histoscanning technology was 81,8%, specificity - 75%, accuracy - 77,7%, PPV - 69,2%, NPV - 85,7% respectively. Conclusion. We can get closer to the new standard of performing prostate biopsy - biopsy of suspicious areas only today.
About the Authors
Alexander Vasilievich Zubarev
President Medical Center
Russian Federation
Russian Federation
Valeriy Vladimirovich Boyarintzev
President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
Anna Aleksandrovna Fedorova
President Medical Center; President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
Svetlana Valerevna Salnikova
President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
Aleksey Aleksandrovich Pavlovichev
President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
Anton Igorevich Lopirev
President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
Ekaterina Jurevna Emelyanova
President Medical Center; President clinical hospital №1 (Volynskaya)
Russian Federation
Russian Federation
References
1. Шолохов В.Н., Бухаркин Б.В., Лепэдату П.И. Ультразвуковая томография в диагностике рака предстательной железы. М.: Стром. 2006; 51 с.
2. Vos E.K., Litjens G.J., Kobus Т. et al. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3T Eur. Urol. 2013; 64 (3): 448-455.
3. Зубарев А.В. Современные возможности визуализации рака предстательной железы при комплексном обследовании. Экспер. и клин. урол. 2011; 2-3: 22-24.
4. Зубарев А.В., Фёдорова А.А. Гистосканирование - новый взгляд на диагностику рака предстательной железы. Поликлиника. 2014; 3 (1): 40-41.
5. Зубарев А.В., Алферов С.М., Фёдорова А.А. Методика гистосканирования в диагностике рака предстательной железы. Кремлевская медицина. 2013; 1: 88-89.
6. Galfano A., Novara G., Lafrate M. et al. Prostate biopsy: the transperineal approach. EAU-EBU. Update Ser. 2007; 5: 241-249.
7. Pokorny M.R., Rooij M. de, Duncan E. et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus Magnetic Resonance (MR) Imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur. Urol. 2014; 66: 22-29.
8. Isebaert S., Van den Bergh L., Haustermans K. et al. Multi parametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J. Magn. Reson. Imaging. 2012; 37 (6): 1392-1401.
9. Postma R., Schoder F.H., van Leenders G.J.L.H. et al. Cancer Detection and Cancer Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam. Eur. J. Cancer. 2005; 41: 825-833.
10. Brawer M.K. Prostate-specific antigen: current status. CA Cancer J. 1999; 49 (5): 264-281.
Review
For citations:
Zubarev A.V., Boyarintzev V.V., Fedorova A.A., Salnikova S.V., Pavlovichev A.A., Lopirev A.I., Emelyanova E.J. Prostate Biopsy under Navigation of Histoscanning Technology. Medical Visualization. 2014;(5):53-63. (In Russ.)
Views:
912
Email this article 